Skip to content
StockMarketAgent
Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0HTG stock hub

LON/0HTG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0HTGis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
31.6B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0HTG
In the news

Latest news · LON/0HTG

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.7
P25 12.9P50 16.9P75 23.5
Trailing P/E26.8
P25 15.9P50 22.9P75 35.8
ROEn/a
P25 -54.2P50 2.1P75 13.7
ROIC81
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0HTG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
224
Groups with data
11
Currency
USD
Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
UK
Employees
55,392
Employees Change
8,800%
Employees Change Percent
18
Enterprise value
$35.3B
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical - Equipment & Services
Isin
US14149Y1082
Last refreshed
2026-05-10
Market cap
$31.6B
Price
$185
Price currency
USD
Rev Per Employee
3,427,983.63x
Sector
Healthcare
Sic
5122
Symbol
lon/0HTG
Website
https://www.cardinalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
3.73%
EV Earnings
30.01x
EV/EBIT
15.68x
EV/EBITDA
11.48x
EV/FCF
10.64x
EV/Sales
0.19x
FCF yield
10.52%
Forward P/E
15.73x
P/B ratio
-15.6x
P/E ratio
26.8x
P/S ratio
0.17x
PE Ratio10 Y
181.09x
PE Ratio3 Y
38.11x
PE Ratio5 Y
35.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
1.22%
EBITDA Margin
1.59%
FCF margin
1.75%
Gross margin
3.76%
Gross Profit
$7.1B
Gross Profit Growth
19.98%
Gross Profit Growth Q
17.66%
Gross Profit Growth3 Y
12.2%
Gross Profit Growth5 Y
6.44%
Net Income
$1.2B
Net Income Growth
-0.13%
Net Income Growth Q
-21.15%
Net Income Growth Years
3%
Net Income Growth3 Y
49.76%
Net Income Growth5 Y
6.2%
Pretax Margin
0.8%
Profit Margin
0.62%
Profit Per Employee
$21,260
Profitable Years
3
ROA
3.6
Roa5y
2.74
ROCE
20.88
ROIC
80.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr1y
22.86%
Cagr3y
32.72%
Cagr5y
29.06%
Div CAGR3
-3.13%
Div CAGR5
0.49%
EPS Growth
2.48
EPS Growth Q
-19.52
EPS Growth Years
3
EPS Growth3 Y
55.43
EPS Growth5 Y
10.85
FCF Growth
78.91%
FCF Growth Q
-39.98%
FCF Growth3 Y
-1.19%
FCF Growth5 Y
22.43%
OCF Growth
69.04%
OCF Growth Q
-37.57%
OCF Growth10 Y
4.57%
OCF Growth3 Y
0.19%
OCF Growth5 Y
20.07%
Revenue Growth
12.8x
Revenue Growth Q
11.05x
Revenue Growth Quarters
4x
Revenue Growth Years
0x
Revenue Growth3 Y
8.07x
Revenue Growth5 Y
9.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$4.71
Assets
$42.9B
Cash
$3B
Current Assets
$27.9B
Current Liabilities
$30.8B
Debt
$6.8B
Debt EBITDA
$2.13
Debt FCF
$2.03
Equity
$-2B
Interest Coverage
10.73
Liabilities
$45B
Long Term Assets
$15B
Long Term Liabilities
$14.2B
Net Cash
$-3.8B
Net Cash By Market Cap
$-11.95
Net Debt EBITDA
$1.25
Net Debt FCF
$1.14
Tangible Book Value
$-12.5B
Tangible Book Value Per Share
$-53.27
WACC
6.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.91
Inventory Turnover
14.13
Net Working Capital
$-5.4B
Quick ratio
0.42
Working Capital
$-3B
Working Capital Turnover
$-63.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
2.36%
Dividend Growth
-4.25%
Dividend Growth Years
1%
Dividend per share
$1.51
Dividend Years
10
Dividend Yield
0.82%
Ex Div Date
2026-04-01
Last Dividend
$0.38
Payout Frequency
Quarterly
Payout Ratio
31.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
22.84%
200-day SMA
189.6
3Y total return
133.82%
50-day SMA
210.4
50-day SMA vs 200-day SMA
50over200
5Y total return
258.01%
All Time High
236
All Time High Change
-21.48%
All Time High Date
2026-03-03
All Time Low
41.92
All Time Low Change
341.96%
All Time Low Date
2019-08-07
ATR
10.8
Beta
0.54
Ch YTD
-10.52
High
190.8
High52
236
High52 Date
2026-03-03
High52ch
-21.48%
Low
185
Low52
137.7
Low52 Date
2025-08-12
Low52ch
34.56%
Ma50ch
-11.92%
Price vs 200-day SMA
-2.3%
RSI
28.17
RSI Monthly
59.43
RSI Weekly
40.9
Sharpe ratio
0.72x
Sortino ratio
1.38
Total Return
3.17%
Tr YTD
-10.08
Tr1m
-12.95%
Tr1w
-4.49%
Tr3m
-18.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
$2.3B
Operating Income Growth
27.81
Operating Income Growth Q
17.78
Operating Income Growth3 Y
23.19
Operating Income Growth5 Y
10.33
Operating margin
1.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
233,745,620%
Net Borrowing
838,406,502
Shares Insiders
0.09%
Shares Institutions
90.64%
Shares Qo Q
-0.42%
Shares Yo Y
-2.36%
Short Ratio
3.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$3B
Average Volume
1,358.85x
Bv Per Share
-9.13
CAPEX
$-467.3M
Ch1m
-12.95
Ch1w
-4.49
Ch1y
21.47
Ch3m
-18.63
Ch3y
122.5
Ch5y
219.1
Ch6m
-8.56
Change
-0.94%
Change From Open
-0.12
Close
187
Days Gap
-0.81
Depreciation Amortization
677,766,936
Dollar Volume
256,599
Earnings Date
2026-04-30
EBIT
$2.3B
EBITDA
$3B
EPS
$4.95
F Score
6
FCF
$3.3B
FCF EV Yield
9.4x
Financing CF
-340,029,945
Fiscal Year End
June
Founded
1,979
Goodwill
8,373,062,310
Income Tax
$345.3M
Investing CF
-2,979,237,870
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Lynch Fair Value
$42.86
Lynch Upside
-76.86
Ma150
202.1
Ma150ch
-8.32%
Ma20
202.1
Ma20ch
-8.34%
Net CF
462,713,355
Next Earnings Date
2026-08-12
Open
185.5
P FCF Ratio
9.51
P OCF Ratio
8.33
Payment Date
2026-04-15
Position In Range
4.64
Ppne
2,147,728,992
Price Date
2026-05-08
Price EBITDA
$10.44
Relative Volume
1.1x
Revenue
189,882,869,175x
SBC By Revenue
0.18x
Share Based Comp
349,874,910
Tax By Revenue
0.18x
Tax Rate
22.75%
Tr6m
-8.11%
Volume
1,385
Z Score
4.99
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/0HTG dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.8%
$1.51 annual per share
Payout ratio
+31.6%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+0.5%
1 consecutive years of growth
Total shareholder yield
+3.2%
Next ex-dividend date: 2026-04-01
Performance

LON/0HTG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+22.8%
S&P 500 1Y: n/a
3Y total return
+133.8%
S&P 500 3Y: n/a
5Y total return
+258.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0HTG?

Insider, institutional, and short-interest positioning.

Institutional ownership
+90.6%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.2 days to cover
Y/Y dilution
-2.4%
Negative means the company is buying back shares.
Technical

LON/0HTG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
28.2
Below 30: short-term oversold
Price vs 200-day MA
-2.3%
50/200-day relationship not available
Beta (5Y)
0.54
Less volatile than the market
Sharpe ratio
0.72
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0HTG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HTG stock rating?

lon/0HTG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HTG analysis?

The full report lives at /stocks/lon/0HTG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HTG?

The latest report frames lon/0HTG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HTG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.